Sarepta Catapults 30% After Hitting A 'Grand Slam' Approval
15:44
Sarepta Catapults 30% After Hitting A 'Grand Slam' Approval
Jun 20, 2024
investors.com
Why Sarepta's halted drug Elevidys is an issue for investors | Haystack News
Why Sarepta's halted drug Elevidys is an issue for investors | Haystac…
4 months ago
haystack.tv
Sarepta can begin shipping Elevidys therapy after FDA reverses pause, stock soars
2:12
Sarepta can begin shipping Elevidys therapy after FDA reverses pause…
4 months ago
aol.comAnjalee Khemlani
1.6K views · 44 reactions | $SRPT soaring on expanded FDA approval for its Duchenne Muscular Dystrophy drug Elevidys @Sarepta CEO Douglas Ingram talks about what it means for the company and patients: | CNBC Fast Money | Facebook
5:32
1.6K views · 44 reactions | $SRPT soaring on expanded FDA approv…
551 viewsJun 21, 2024
FacebookCNBC Fast Money
Sarepta Therapeutics (SRPT) Declines Again On EMA Recommendation to Refuse ELEVIDYS Marketing Authorization, Securities Class Action Pending – Hagens Berman
Sarepta Therapeutics (SRPT) Declines Again On EMA Recomme…
4 months ago
fox2now.com
Sarepta Reorganizes Strategy, Focuses Pipeline Amid ELEVIDYS Progress – Archyde
Sarepta Reorganizes Strategy, Focuses Pipeline Amid ELEVIDYS …
5 months ago
archyde.com
La FDA Recommande à Sarepta de Reprendre les Expéditions d'Elevidys pour les Patients Ambulatoires Atteints de Dystrophie Musculaire de Duchenne
La FDA Recommande à Sarepta de Reprendre les Expéditions d'Elevi…
4 months ago
zonebourse.com
2:30
Sarepta resumes shipping of gene therapy Elevidys to patients who c…
4 months ago
MSNCNBC
Les actions de Sarepta rebondissent après la reprise des livraisons de l…
4 months ago
zonebourse.com
3:57
Sarepta under pressure: FDA requests halt of Elevidys shipments
13.8K views4 months ago
YahooYahoo Finance Video
SRPT Slides on Voluntary US Elevidys Shipment Pause Amid Sc…
4 months ago
YahooZacks Equity Research
5 questions on Sarepta, the FDA and a Duchenne gene therapy crisis
4 months ago
YahooBen Fidler,Ned Pagliarulo
Sarepta’s Elevidys Death, FDA’s Vaccine Move, Weldon Whiplash, …
9 months ago
biospace.com
5:43
Goldman Sachs' Salveen Richter on Sarepta's ongoing troubles, oppor…
4 months ago
MSNCNBC
FDA Investigates Patient Death Linked to Sarepta's Elevidys Ther…
4 months ago
archyde.com
Sarepta halts three studies testing gene therapy for muscle disorder
8 months ago
bluewaterhealthyliving.com
19:19
The story of Sarepta's Duchenne gene therapy
4 months ago
MSNSTAT News Video - Video
1:38
Pharma and Biotech Daily: FDA Voucher Program, Sarepta's Elevi…
3 weeks ago
YouTubeOWITH
2:19
Biotech Buzz: Safety data on Elevidys, Arrowhead's rise, and N…
3 weeks ago
YouTubeOWITH
0:31
ELEVIDYS: WARNING IN THE SHADOWS #ELEVIDYS #Sarepta #…
18 views3 weeks ago
YouTubeInvestin2life
10:01
ELEVIDYS Update: FDA Approves New Safety Labeling for Duchenn…
8 views1 month ago
YouTubeVoices Without Borders
1:14
Pharma and Biotech Daily: Elevidys setback, Lilly's big commitment, a…
1 views3 weeks ago
YouTubeOWITH
4:19
Sarepta's ELEVIDYS: New Study for Non-Ambulant Duchenne Patients …
1 views2 weeks ago
YouTubeWanderer’s Path
14:37
SRPT STOCK - The FDA Scandal, a Failed Trial, and Why I Sold My SR…
255 views3 weeks ago
YouTubeThe Biotech Investor
8:56
[FullVer] Sarepta Therapeutics Mystery | Why Does the Market Di…
43 views1 month ago
YouTubeVALUETER: THE STOCK DETECTIVE
4:16
Sarepta Therapeutics Q3 2025 Financial Results and ESSENCE S…
4 views1 month ago
YouTubeFuture Spot
25:57
Elevidys¿Quién puede pagar por vivir?
27 views2 months ago
YouTubeHistoria de los medicamentos
5:26
FDA Approves Updated Prescribing Info for ELEVIDYS: What You Nee…
2 weeks ago
YouTubeTrí Tuệ Sáng Suốt
Sarepta surges on expanded approval of muscular dystrophy d…
Jun 21, 2024
Yahoo
See more videos
Static thumbnail place holder